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Abstract
Background
In Kenya data on the burden of influenza disease are needed to inform influenza control
policies.
Methods
We conducted a systematic review of published data describing the influenza disease bur-
den in Kenya using surveillance data collected until December 2013. We included studies
with laboratory confirmation of influenza, well-defined catchment populations, case defini-
tions used to sample patients for testing and a description of the laboratory methods used
for influenza testing. Studies with or without any adjustments on the incidence rates were
included.
Results
Ten studies reporting the incidence of medically-attended and non-medically attended influ-
enza were reviewed. For all age groups, the influenza positive proportion ranged from
5–10% among hospitalized patients, and 5–27% among all medically-attended patients (a
combination of in- and outpatients). The adjusted incidence rate of hospitalizations with
influenza among children <5 years ranged from 2.7–4.7 per 1,000 [5.7 per 1,000 in children
<6 months old], and were 7–10 times higher compared to persons aged5 years. The
adjusted incidence of all medically-attended influenza among children aged <5 years ran-
ged from 13.0–58.0 per 1,000 compared to 4.3–26.0 per 1,000 among persons aged5
years.
Conclusions
Our review shows an expanding set of literature on disease burden associated with influ-
enza in Kenya, with a substantial burden in children under five years of age. Hospitaliza-
tions with influenza in these children were 2–3 times higher than reported in the United
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States. These findings highlight the possible value of an influenza vaccination program in
Kenya, with children <5 years and pregnant women being potentially important targets.
Introduction
Human influenza infections are a major cause of morbidity and mortality worldwide [1–3].
Although risk factor data from tropical climates are limited, young children (<5 years), preg-
nant women, the elderly, and persons with underlying medical conditions have been shown to
be at increased risk of severe disease [1, 4]. A recent study estimated that there were 20 million
cases of influenza associated with pneumonia; 1 million cases of influenza associated with
severe pneumonia; and 28000–111500 deaths associated with influenza among children aged
<5 years globally in 2008, with 99% of these deaths occurring in the developing world [5]. A
summary of existing direct estimates of influenza disease burden in tropical and developing
countries is needed to validate global modeling efforts that suggest a disproportionate burden
in these countries.
In Kenya, influenza surveillance was established partly in response to the global emerging
threat of avian influenza A(H5N1)[6, 7]. As is the case with other tropical and sub-tropical
countries, influenza viruses circulate in Kenya for most of the year [7–9] and morbidity (hospi-
talization and outpatient) burden of influenza have only recently been described [10–18].
An improved understanding of disease burden in Kenya relating to morbidity, mortality,
and economic losses is needed to support decisions involving the allocation of limited
resources toward influenza control programs. The Kenyan Ministry of Health (KMoH) has
released its first ever influenza vaccination policy [19] and this has necessitated the publication
of an overview of the burden of influenza in Kenya to inform initial vaccination pilot activities.
In this article, we review existing data on the influenza disease burden in Kenya using data
collected until December 2013. We summarize published data describing the health burden of
human influenza collected through population-based influenza surveillance systems in Kenya.
We also discuss the various disease burden estimation methods used and provide suggestions
for future research strategies that will help to generate additional data needed to inform influ-
enza control strategies.
Methods
Search strategy and selection criteria
Our objective is to provide a comprehensive overview of the disease burden of influenza in
Kenya. We carried out a literature review with specific search terms; "Kenya" and each of the
following words "Influenza", "Respiratory", "Pneumonia", "Severe Acute Respiratory Illness",
and "Influenza-like Illness". We searched PubMed and EMBASE (Ovid) for studies–with no
language restrictions—that contained original data and were conducted until December 2013.
The search was last conducted on March 23, 2015. We created a master list of the search results
from these two search databases with two variables; author names and study title. We then
removed duplicates. Titles from these search results were reviewed for the presence of any of
the following key words; “Kenya”, “Influenza”, “respiratory”, “pneumonia”, “influenza-like ill-
ness”, “acute lower respiratory infection”, “acute upper respiratory infection”, “mortality”,
“deaths”, “hospitalization”, “hospital admission”, and “outpatient”. Abstracts of articles that
contained at least one of these search words were then reviewed by one researcher (GOE) and
included if they contained information on disease burden of influenza in Kenya.
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Only studies with original data collected before December 2013 were included. We consid-
ered studies for inclusion: (i) if they reported incidence rates of hospitalization and/or outpa-
tient visits associated with influenza-like illness (ILI), acute respiratory illness (ARI), acute
lower respiratory illness (ALRI), severe respiratory illness (SARI), and severe or very severe
pneumonia using laboratory confirmed influenza cases; (ii) if they had well-defined catchment
populations or estimations of the population-at-risk [using any of population-based disease
surveillance systems, health demographic surveillance systems (HDSS), national population
census data, or population registration records]; (iii) if they provided the case definition used
to sample patients for testing; and (iv) if they provided a description of the laboratory testing
methods used. Studies that presented adjusted or unadjusted (crude) incidence rates were
included in the review (see S1 File, for a summary of the formulae used for the adjustments).
All reported rate adjustments are indicated for each study. Additionally, we scanned the refer-
ence lists and titles of articles selected for review using the criteria defined above.
A flow chart with details of the process followed in selecting the articles that were reviewed,
and the number of articles included–and excluded from this review is provided in Fig 1.
Data extraction, analysis and reporting
Data extraction was performed by one researcher (GOE) using a template that collected details
on study characteristics [title, author(s), publication year, place of study, study participants age
group, syndromes used for case identification, and adjustment factors used for calculating inci-
dence rates]. The adjustments applied to the rates were limited to one or more of the following:
(i) patients who met the swabbing criteria but were not tested for influenza; (ii) cases in the
community who met the specific case definition but did not seek healthcare at the study hospi-
tal/clinic; and (iii) asymptomatic detection of influenza using controls to determine illness
attributable to influenza. In this review, we reported both adjusted and unadjusted influenza
burden disease rates, but our primary measure was the adjusted rates as these were more accu-
rate estimates of the disease burden.
The outcome measures that we considered were incidence of: (i) hospitalizations with influ-
enza; (ii) medically-attended influenza (outpatient and inpatient combined); and (iii) non-
medically attended influenza. We also, as a secondary measure, reported on the proportion of
those who tested positive for influenza if data on incidence of influenza illness were reported.
Other than the conditions defined in the inclusion criteria, no further quality assessments were
applied to the reviewed articles. All incidence rates were reported per 1,000 persons or person-
years. Adjusted rates reported in our paper included at least an adjustment for patients who
met the swabbing criteria but were not tested, which was the most commonly applied adjust-
ment in the studies that we reviewed.
Data from the articles reviewed were summarized as ranges (minimum—maximum), where
two or more studies were involved, and presented in tables by the following domains: (i) pro-
portions testing positive for influenza; (ii) hospitalizations with influenza; (iii) medically-
attended influenza; and (iv) non-medically attended influenza.
Results
Search results and description of methods used
There were a total of 1,273 search records returned, including duplicates (PubMed = 739; and
EMBASE = 534) (Fig 1). After removing duplicates, there were 715 unique articles that were
returned from the search and among these were 555 (78%) were on subjects not related to
influenza or respiratory illness and were excluded in the first round of screening. Of the
remaining 160 articles, there were 51 articles on an influenza related subject; 67 on pneumonia,
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and 42 on a broader respiratory subject other than influenza and pneumonia. Of these 160 arti-
cles, 10 met the inclusion criteria for this review.
Fig 2 shows the location of the study sites that generated the data that were used in the anal-
ysis for articles that we reviewed. Eight of the 10 articles reviewed were based on surveillance
data collected by the Kenya Medical Research Institute (KEMRI) and the Centers for Disease
Control and Prevention (CDC) [10–14, 17, 18, 20]. The remaining two articles were based on
data collected by the KEMRI and Wellcome Trust Research Program [15, 16]. Of the ten arti-
cles reviewed, one was published in 2010 [15], five in 2012 [11–13, 16, 17], two in 2013 [10,
14], one in 2014 [18] and one in 2015 [20]. Case definitions used in two of these articles
Fig 1. Overview of the different phases of literature selection.
doi:10.1371/journal.pone.0138708.g001
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included data on severe or very severe pneumonia [15, 16]; six included data on severe acute
respiratory illness (SARI) or acute lower respiratory illness (ALRI)[10, 11, 14, 17, 18, 20]; two
included data on influenza-like illness (ILI) [11, 18]; and two included data on acute respiratory
illness (ARI) [12, 13].
The case definitions for the respiratory syndromes used in identifying the cases to be tested
for influenza varied (Table A in S1 Table). Six of the articles reviewed used mid-year popula-
tion data from well-defined catchment areas as denominators, either from a HDSS, refugee
camp records, or national census data for estimation of incidence while the rest used person-
time years of follow-up calculated from a population-based surveillance system. All ten articles
that reported influenza A and/or B testing, used reverse transcriptase polymerase chain reac-
tion (RT-PCR) testing methods. The data reported in all the papers reviewed were collected
year-round, and all (except one [15]) of the papers had multiple years of data included. All–
except one [15]—of the articles included data collected during the 2009 pandemic period.
Fig 2. Map of Kenya showing the study sites which generated data that was used in the reviewed
papers.
doi:10.1371/journal.pone.0138708.g002
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Most (9/10) of the articles reported data on the proportions of patients who tested positive
for influenza (Table B in S1 Table). Six of the nine articles reported rates of hospitalization
with influenza (Table 1), four reported rates of medically-attended influenza (both in- and out-
patients) (Table 2), and two reported incidence of non-medically attended SARI or ILI [10, 18]
(Table 3). None of the studies reviewed had data on influenza mortality in Kenya.
Proportions testing positive for influenza
The proportions of those who tested positive for influenza A and/or B varied among the studies
included (Table B in S1 Table). These ranged from 4.9% to 26.7% for all medically-attended
patients [4.9% to 13.7% among children<5 years; 14.0% to 20.5% among persons5 years;
and 9.8% to 26.7% in studies that reported proportions among patients of all ages]. Among
hospitalized patients who were tested, the proportion of those who tested positive for influenza
A and/or B ranged from 5% to 10%.
Incidence rate of hospitalization with influenza
Incidence rates of hospitalization with influenza varied among the studies, which were imple-
mented during different years, and used varying case definitions, and adjustments factors
Table 1. Average annual incidence rates of hospitalization with influenza for different respiratory syndromes (per 1,000 persons or person-years)
in Kenya.
Author(s) Syndrome type Adjustment used Study site Age
group
Incidencea
Rangeb
Berkley et al. (2010)[15]
and Onyango et al. (2012)
[16]
Hospitalized Severe or
very severe pneumonia
None stated Kiliﬁ < 1 yr 1.5–2.4
<5 yrs 0.6–0.8
Ahmed et al. (2012)[17] Hospitalized SARI None stated Kakuma &
Dadaab refugee
camp
< 1 yr 10.3–12.3
< 5 yrs 4.2–5.6
Fuller et al. (2013)[10] and
Emukule et al. (2014)[18]
Hospitalized SARI Healthcare seeking; those with syndrome
who did not have swabs tested for inﬂuenza
virus
Siaya, Western
Kenya
<6 mos 5.7
<5 yrs 2.7–4.7
5 yrs 0.2–0.4
All ages 0.7–1.1
Feikin et al. (2012)[12] Hospitalized ARI Rates adjusted for those hospitalized with
ARI who did not have swabs tested for
inﬂuenza
Bondo, Western
Kenya
<1 yr 1.4
<5 yrs 1.4
All ages 0.6
All studies All syndromes With or without any adjustment All study sites <6 mos 5.7
<1 yr 1.4–12.3
<5 yrs 0.6–5.6
5 yrs 0.2–0.4
All ages 0.6–1.1
Abbreviations
SARI = Severe acute respiratory illness
ARI = Acute respiratory illness.
aIncidence reported per 1,000 persons or person-years
bRange is the minimum-maximum in cases where two or more studies were involved.
doi:10.1371/journal.pone.0138708.t001
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(Table 1 and Table C in S1 Table). There were six studies that reported incidence rates of hospi-
talization with influenza. Two studies conducted among children with severe or very severe
pneumonia reported similar incidence rates among children<5 years [0.8 cases per 1,000 in
the first study, and 0.6 cases per 1,000 (95% CI 0.5–0.7) in the second study] [15, 16]. No
adjustments for people with pneumonia who were not tested were reported in these two stud-
ies. Unadjusted rates of influenza among hospitalized children in the age group<5 years were
also reported in a study conducted in two refugee sites. These unadjusted rates ranged 4.2–5.6
cases per 1,000 for influenza A viruses and 1.1–1.4 for influenza B viruses.
Adjusted incidence rates of hospitalization with influenza among children of the age group
of<5 years who presented with SARI ranged from 2.7–4.7 per 1,000 [10, 18]. Adjusted inci-
dence rates of hospitalization with influenza among persons aged5 years who presented with
SARI ranged from 0.2–0.4 per 1,000 among persons aged5 years, and were lower compared
to those of children in the age group of<5 years. In Western Kenya there was a high incidence
rate of hospitalization with influenza among children<6 months [5.7(95% CI 2.4–13.8) per
1,000][18].
Incidence rate of medically-attended influenza
Over the study period covered in our review, there were three publications that reported
broader medically-attended (combining in- and outpatients) influenza incidence rates. Two of
the publications were based on medically-attended ALRI [11, 14]; and another on medically-
attended ARI [13]. Two studies reported medically-attended influenza incidence rates only for
outpatients [18, 20]. The adjusted incidence rates of medically-attended influenza ranged from
21.8–58.0 per 1,000 child-years for children in the age group of<5 and 4.3–26.0 for persons
aged5 years (Table 2 and Table D in S1 Table).
A study that was conducted in a peri-urban informal settlement in Nairobi (Kibera) and a
rural site in Western Kenya (Lwak) among patients who sought care for ALRI as inpatients
and/or outpatients, reported higher adjusted incidence rates for influenza among children<5
years in the rural site [40.5 (95% CI 31.2–52.6)] compared to the urban site [22.0 (95% CI
17.7–26.6)]. However, similar results were reported among persons5 years [15.8 (95% CI
14.1–17.7) vs. 12.0 (95% CI 10.3–13.3)] in the rural and urban sites respectively [11] (Table D
in S1 Table).
Incidence rate of non-medically attended influenza
Only two of the studies reviewed (both conducted in Western Kenya) estimated non-medically
attended incidence rates of influenza (two reported non-medically attended SARI in Siaya [10,
18]; and one reported non-medically attended ILI [18]). The incidence of influenza with non-
medically attended severe ARI ranged from 2.9–5.1 per 1,000 among children<5 years, and
0.4–0.8 among persons aged5 years. In the one study that estimated incidence of influenza
among non-medically attended ILI cases, there were an estimated 30.1 cases of influenza per
1,000 (95% CI 27.3–33.3) among children<5 years and 5.4 cases per 1,000 (95% CI 4.9–6.0)
among persons aged5 years [18] (Table 3 and Table E in S1 Table).
Discussion
We have provided a comprehensive summary of available data on disease burden of influenza
in Kenya and we show that influenza is an important cause of respiratory infection-associated
morbidity, especially among younger children under the age of five years. Indeed, both
adjusted and unadjusted incidence rates of hospitalization with influenza [10, 17, 18], and
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outpatient visits[18] were higher than those that have been reported in United States and Euro-
pean countries during similar time periods [21–32].
We also note that the published literature on the burden of influenza in Kenya is limited but
expanding. Eight of the ten papers that we reviewed were published within the last three years
(2012–2014)–including two studies that published data on the post- pandemic A(H1N1)
period. This could be attributed to the interest generated by the threat of avian and pandemic
influenza.
Our review showed that there were an estimated 2.7–4.7 cases of influenza per 1,000 among
children<5 years who were hospitalized with severe acute respiratory illness (SARI). These
were 7–10 times higher compared to those in persons aged5 years. A study that estimated
disease burden among hospitalized children<6 months in Western Kenya reported that there
were 5.7 cases of influenza per 1,000 [18]. This is consistent with data from several other coun-
tries [22, 23, 33], and shows a considerable burden of disease in young infants for whom
Table 2. Average annual incidence rates of medically-attended influenza A and/or B (hospitalized and outpatient) per 1,000 persons or person-
years in Kenya.
Author(s) Syndrome type Adjustment used Study site Age
group
Incidencea
Rangeb
Katz et al.
(2012)[11]
In- and
outpatient ALRI
Adjusted for those with ALRI who were not tested for inﬂuenza Kibera and Lwak < 1 yr 32.8–42.1
<5 yrs 22.0–40.5
5 yrs 12.0–15.8
All ages 13.7–23.0
Feikin et al.
(2013)[14]
In- and
outpatient SARI
Adjusted for healthcare seeking by extrapolating from those with
ARIǂ at household visit who sought care at a clinic besides the
study clinic and for the pathogen-attributable fraction (PAF¥)
Lwak, Western
Kenya
<5 yrs 58.0
Breiman et al.
(2015)[20]
Outpatient SARI Adjusted for healthcare seeking for SARI at the study clinic and for
the pathogen-attributable fraction (PAF¥).
Kibera <5 yrs 13.0
Feikin et al.
(2012)[13]
In- and
outpatient ARI
Adjusted for healthcare seeking by extrapolating from those with
ARIǂ at household visit who sought care at a clinic besides the
study clinic and for the pathogen-attributable fraction (PAF¥)
Lwak, Western
Kenya
5 yrs 26.0
Emukule et al.
(2014)[18]
Outpatient ILI Adjusted for those with ILI who were not tested for inﬂuenza Ting'wang'i,
Western Kenya
<6 mos 16.2
<5 yrs 21.8
5 yrs 4.3
All ages 7.2
All studies All syndromes With any adjustment All study sites <6 mos 16.2
< 1 yr 32.8–42.1
<5 yrs 21.8–58.0
5 yrs 4.3–26.0
All ages 7.2–23.0
Abbreviations
SARI = Severe acute respiratory illness
ALRI = Acute lower respiratory illness
ILI = inﬂuenza-like illness
ARI = Acute respiratory illness
aIncidence reported per 1,000 persons or person-years
bRange is the minimum-maximum in cases where two or more studies were involved
ǂARI in home was deﬁned as cough, difﬁculty breathing or chest pain and reported fever
¥Adjusted rates downward for asymptomatic detection of inﬂuenza in controls.
doi:10.1371/journal.pone.0138708.t002
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influenza vaccination is not recommended, and also highlights the rationale for targeting preg-
nant mothers for influenza vaccination [34]. Whereas pregnant mothers have been shown to
be at increased risk of complications associated with influenza [35], vaccinating them may not
only be beneficial to them but could also offer protection to their young infants—for whom no
influenza vaccine is currently licensed—through breastfeeding and trans-placental antibody
transfer [36, 37].
The incidence rates of hospitalization with influenza among children<5 years reported at
the two refugee sites (Kakuma and Dadaab)–without adjustments for eligible cases who were
not tested—were higher than rates reported elsewhere in Kenya. This could be due to the
unique challenges experienced by the populations in refugee settings, such as population den-
sity, which could make them more vulnerable to exposure to respiratory infections [38, 39].
While the incidence rates of hospitalization with influenza are similar to those reported in
South Africa [40], Asia [41–46], Latin America [47], some of the reported rates were up to
seven times higher than rates reported in the United States [21–26] and Europe [27, 28]. The
incidence rates of hospitalization with influenza children<6 months in Kenya, for example,
were 2–3 times higher than rates reported in the United States [23].
The adjusted incidence of medically-attended (outpatient + inpatient) influenza among
children<5 years ranged from 21.8 to 58.0, and 4.3 to 26.0 per 1,000 among persons aged5
years in different studies. These rates were similar to rates reported in Asia [48], but up to 2–4
times higher than annual estimates reported in Europe [29–31], and up to 2–8 times higher
than rates reported in the United States [32].
The incidence of non-medically attended severe ARI associated with influenza suggested a
burden of disease that was similar to the medically-attended burden. As reported in the health
utilization survey conducted in Western Kenya, 52% of children<5 years and 66% of persons
5 years who reported to have had pneumonia did not seek care at a hospital [49]. The similar-
ity between the medically-attended and non-medically attended incidence not only under-
scores the fact that there is a considerable burden of non-medically attended influenza, but also
highlights the low levels of health-care seeking for respiratory illness in Kenya [49]. These find-
ings also suggest that surveillance limited to the health care setting will not capture the entire
burden of influenza severe respiratory illness in contexts such as Kenya.
Table 3. Non-medically attended average annual incidence rates of Influenza reported for different respiratory syndromes (per 1,000 persons or
person-years) in Kenya.
Author(s) Syndrome type Adjustment used Study site Age
group
Incidencea
Rangeb
Fuller et al. (2013)[10];
Emukule et al. (2014)[18]
Non-medically
attended SARI
Adjusted for persons with pneumonia who did not seek
care from health utilization survey (HUS)
Siaya <6 mos 6.2
<5 yrs 2.9–5.1
5 yrs 0.4–0.8
All ages 0.9–1.4
Emukule et al. (2014)[18] Non-medically
attended ILI
Adjusted for persons with ARI who did not seek care
from HUS
Ting'wang'i <6 mos 22.3
<5 yrs 30.1
5 yrs 5.4
All ages 9.1
aIncidence reported per 1,000 persons or person-years
bRange is the minimum-maximum in cases where two or more studies were involved.
doi:10.1371/journal.pone.0138708.t003
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The studies reviewed included various adjustments for patients who met the case definitions
but were not tested for influenza [10–12, 18]; for those who sought health-care at a facility
other than the one used for estimating the incidence rates [13, 14]; and for asymptomatic
detection of influenza among controls [13, 14]. The first two adjustments would serve to
increase the crude incidence to account for persons who met the case definition and were not
tested for influenza or those who did not seek care; while the latter would drive the rate down-
wards by only accounting for the cases for which the virus was the likely cause disease. Other
than the case definition for ILI developed by the World Health Organization (WHO) which
was more commonly applied across the different studies [50], the case definitions used for
SARI, ALRI and ARI also substantially varied across the studies reviewed. In order to facilitate
disease burden comparisons over time, it would have been helpful if researchers also presented
their data using standard case definitions as recommended by WHO[51]; and unadjusted rates
in addition to those where adjustments were applied. These standardizations, in addition to
presenting data in age groups that may be aggregated to WHO recommended age categories
[<2, 2–4, 5–14, 15–49, 50–64, and65 years] [51] would help to facilitate comparisons across
studies and across countries [52].
All the articles reviewed utilized data generated from well-defined catchment areas managed
by either the KEMRI and CDC, or the KEMRI and Wellcome Trust research collaboration;
indeed a majority of the articles reviewed included KEMRI and CDC co-authors who are also
authors on this paper. Additionally, all the papers that we reviewed included in their analysis
data that were collected year-round and a majority of them had multiple years of data used in
estimating incidence rates. This consideration is important because–other than considering
that influenza circulates in Kenya year-round [7]–it minimizes the risk of overestimating the
disease burden by only sampling during epidemic periods.
Six of the ten studies reviewed utilized mid-year population denominators, derived from
HDSS or National census data [12], for the estimation of incidence rates. As opposed to using
denominators derived from individual follow-up (person-time) in population-based surveil-
lance systems, denominators based on mid-year population could potentially underestimate
the incidence rates as they may not accurately reflect the actual population dynamics relating
to births, migrations and deaths, especially if smaller populations are involved [53]. However,
using either of these two denominator types to estimate incidence rates would normally yield
nearly identical results for large populations. Taken in the context of the resources required to
set-up and run a population-based surveillance system, denominators derived from mid-year
population numbers may be useful for disease burden estimation in Kenya for the foreseeable
future.
Only one study reported rates among children<6 months, and a few reported data on those
aged50 years [11, 12] which is in part explained by the lower health-seeking behavior among
older persons in Kenya [49], and perhaps also by a diminished likelihood that older patients
will report the fever required to meet the WHO SARI case definition. Understanding the dis-
ease burden, especially in the high risk groups which include pregnant women, and people
with underlying medical conditions; as well as understanding the socio-economic (direct and
in-direct) burden of influenza in Kenya would be helpful to public-health and influenza control
programs and understanding the impact of influenza. For example a recent study conducted in
Western Kenya showed a substantial burden of influenza (3-times higher) among HIV-
infected adults aged18 compared to their HIV-negative counterparts [13]. Another study in
South Africa reported 4–8 times greater incidence of acute lower respiratory tract infection
(LRTI) with influenza among HIV-infected compared to HIV-uninfected persons [40].
Our study was subject to limitations. First, we may have missed some articles as we limited
our review to only published data searched the PubMed and EMBASE databases. However, we
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believe that the likelihood of finding additional data relevant to our study in other databases is
very low. Second, most of the published data summarized in our review included data from the
2009 pandemic influenza period and may have served to overestimate the seasonal influenza
disease burden. Third, the reviewed papers were limited to respiratory surveillance only. For
some populations (particularly young infants) presentation may be fever without respiratory
symptoms. As such, the true burden among children may have been underestimated. Fourth,
the clinical threshold to hospitalize in Kenya may not be comparable to US or Europe and
therefore hospitalization rates should be interpreted with caution when making these compari-
sons. Fifth, most of the studies presented data on incidence of influenza without presenting
either the age-specific denominators or age-specific numbers of cases. Taken together with the
fact that there were varied case definitions and adjustments applied, this made it difficult for us
to calculate meta-analytic rates of influenza disease burden in Kenya. Lastly, while not a direct
limitation of our methods, the absence of data on influenza mortality remains a gap that needs
to be addressed in order to inform influenza vaccine policy.
In conclusion, our literature review provides a comprehensive summary of available data on
the disease burden of influenza in Kenya over the past 8 years, and shows a substantial medi-
cally- and non-medically attended disease burden among children aged<5 years. Additional
research gaps identified in the review include the lack of influenza mortality and socio-eco-
nomic disease burden data. While these additional data would be very helpful to policy makers
and other stakeholders to inform prevention and treatment policies, the current data in Kenya
indicate an important burden of influenza in young children that might be reduced with a tar-
geted vaccination program including children and pregnant women. However, any decision
about influenza vaccination must look at its burden relative to other respiratory pathogens
such as respiratory syncytial virus–when a vaccine becomes available—and even non-respira-
tory vaccine preventable diseases.
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